132 related articles for article (PubMed ID: 11419909)
1. The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients.
Hashim OH; Shuib AS; Chua CT
Immunol Invest; 2001 Feb; 30(1):21-31. PubMed ID: 11419909
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains.
Hashim OH; Shuib AS; Chua CT
Nephron; 2001 Dec; 89(4):422-5. PubMed ID: 11721160
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura.
Saulsbury FT
J Rheumatol; 1997 Nov; 24(11):2246-9. PubMed ID: 9375892
[TBL] [Abstract][Full Text] [Related]
4. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
Leung JC; Poon PY; Lai KN
J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
[TBL] [Abstract][Full Text] [Related]
5. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
[TBL] [Abstract][Full Text] [Related]
6. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy.
Hiki Y; Iwase H; Saitoh M; Saitoh Y; Horii A; Hotta K; Kobayashi Y
Nephron; 1996; 72(3):429-35. PubMed ID: 8852492
[TBL] [Abstract][Full Text] [Related]
9. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.
Moore JS; Kulhavy R; Tomana M; Moldoveanu Z; Suzuki H; Brown R; Hall S; Kilian M; Poulsen K; Mestecky J; Julian BA; Novak J
Mol Immunol; 2007 Apr; 44(10):2598-604. PubMed ID: 17275907
[TBL] [Abstract][Full Text] [Related]
10. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
11. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
Linossier MT; Palle S; Berthoux F
Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
[TBL] [Abstract][Full Text] [Related]
12. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
13. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
14. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.
Tomana M; Matousovic K; Julian BA; Radl J; Konecny K; Mestecky J
Kidney Int; 1997 Aug; 52(2):509-16. PubMed ID: 9264010
[TBL] [Abstract][Full Text] [Related]
15. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Moldoveanu Z; Wyatt RJ; Lee JY; Tomana M; Julian BA; Mestecky J; Huang WQ; Anreddy SR; Hall S; Hastings MC; Lau KK; Cook WJ; Novak J
Kidney Int; 2007 Jun; 71(11):1148-54. PubMed ID: 17342176
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
Leung JC; Chan LY; Tang SC; Tam PC; Fenn J; Lai KN
Nephron Exp Nephrol; 2007; 107(3):e107-18. PubMed ID: 17957128
[TBL] [Abstract][Full Text] [Related]
17. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
Allen AC; Bailey EM; Barratt J; Buck KS; Feehally J
J Am Soc Nephrol; 1999 Aug; 10(8):1763-71. PubMed ID: 10446944
[TBL] [Abstract][Full Text] [Related]
18. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
Odani H; Hiki Y; Takahashi M; Nishimoto A; Yasuda Y; Iwase H; Shinzato T; Maeda K
Biochem Biophys Res Commun; 2000 Apr; 271(1):268-74. PubMed ID: 10777713
[TBL] [Abstract][Full Text] [Related]
19. Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjögren's syndrome.
Basset C; Durand V; Jamin C; Clément J; Pennec Y; Youinou P; Dueymes M; Roitt IM
Scand J Immunol; 2000 Mar; 51(3):300-6. PubMed ID: 10736100
[TBL] [Abstract][Full Text] [Related]
20. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis.
Allen AC; Willis FR; Beattie TJ; Feehally J
Nephrol Dial Transplant; 1998 Apr; 13(4):930-4. PubMed ID: 9568852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
